Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) meeting, virtual gathering, 17–21 February 2025

IF 4.5 3区医学 Q2 IMMUNOLOGY

Vaccine Pub Date : 2025-06-09 DOI:10.1016/j.vaccine.2025.127384

Philipp Lambach , Sheetal Silal , Alyssa N. Sbarra , Mitsuki Koh , Rakesh Aggarwal , Habib Hasan Farooqui , Stefan Flasche , Alexandra B. Hogan , Sun-Young Kim , Kathy Leung , William J. Moss , Allison Portnoy , Meru Sheel , Xuan-Yi Wang

{"title":"Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) meeting, virtual gathering, 17–21 February 2025","authors":"Philipp Lambach , Sheetal Silal , Alyssa N. Sbarra , Mitsuki Koh , Rakesh Aggarwal , Habib Hasan Farooqui , Stefan Flasche , Alexandra B. Hogan , Sun-Young Kim , Kathy Leung , William J. Moss , Allison Portnoy , Meru Sheel , Xuan-Yi Wang","doi":"10.1016/j.vaccine.2025.127384","DOIUrl":null,"url":null,"abstract":"<div><div>The Immunization and Vaccines-related Implementation Research Advisory Committee (IVIR-AC) serves as the World Health Organization's (WHO) key advisory body for independently reviewing research that assesses the impact and value of vaccines, particularly using transmission and economic modeling analyses. During its first semi-annual meeting of 2025, held on 17–21 February and complemented by ad hoc sessions on 5 February, 11 April and 14 April, IVIR-AC provided feedback and recommendations across seven key sessions. This report summarizes the discussions and outcomes of the meeting. Topics covered included immunization research priorities in the WHO Eastern Mediterranean region, multi-model comparisons of typhoid conjugate vaccine schedules, a malaria intervention multi-model comparison, a full value assessment of invasive non-typhoidal <em>Salmonella</em> (iNTS) vaccination, an evaluation of improved influenza vaccines, vaccine impact modeling under the Immunization Agenda 2030 (IA2030) framework, and combination vaccines value assessment.</div></div>","PeriodicalId":23491,"journal":{"name":"Vaccine","volume":"61 ","pages":"Article 127384"},"PeriodicalIF":4.5000,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0264410X25006814","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

The Immunization and Vaccines-related Implementation Research Advisory Committee (IVIR-AC) serves as the World Health Organization's (WHO) key advisory body for independently reviewing research that assesses the impact and value of vaccines, particularly using transmission and economic modeling analyses. During its first semi-annual meeting of 2025, held on 17–21 February and complemented by ad hoc sessions on 5 February, 11 April and 14 April, IVIR-AC provided feedback and recommendations across seven key sessions. This report summarizes the discussions and outcomes of the meeting. Topics covered included immunization research priorities in the WHO Eastern Mediterranean region, multi-model comparisons of typhoid conjugate vaccine schedules, a malaria intervention multi-model comparison, a full value assessment of invasive non-typhoidal Salmonella (iNTS) vaccination, an evaluation of improved influenza vaccines, vaccine impact modeling under the Immunization Agenda 2030 (IA2030) framework, and combination vaccines value assessment.

查看原文本刊更多论文

世界卫生组织免疫和疫苗相关实施研究咨询委员会（IVIR-AC）虚拟会议报告，2025年2月17日至21日

免疫和疫苗相关实施研究咨询委员会（IVIR-AC）是世界卫生组织（世卫组织）的主要咨询机构，负责独立审查评估疫苗影响和价值的研究，特别是使用传播和经济模型分析。在2月17日至21日举行的2025年第一次半年度会议上，并在2月5日、4月11日和4月14日举行了临时会议，咨询委员会在七个关键会议上提供了反馈和建议。本报告总结了会议的讨论和成果。涉及的主题包括世卫组织东地中海区域的免疫研究重点、伤寒结合疫苗时间表的多模式比较、疟疾干预的多模式比较、侵入性非伤寒沙门氏菌（iNTS）疫苗接种的全面价值评估、改进流感疫苗的评估、《2030年免疫议程》框架下的疫苗影响建模以及联合疫苗价值评估。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Vaccine 医学-免疫学

CiteScore

8.70

自引率

5.50%

发文量

992

审稿时长

131 days

期刊介绍： Vaccine is unique in publishing the highest quality science across all disciplines relevant to the field of vaccinology - all original article submissions across basic and clinical research, vaccine manufacturing, history, public policy, behavioral science and ethics, social sciences, safety, and many other related areas are welcomed. The submission categories as given in the Guide for Authors indicate where we receive the most papers. Papers outside these major areas are also welcome and authors are encouraged to contact us with specific questions.